Promoting Consistent Shoe Use Among Children At High Risk for Podoconiosis
2 other identifiers
observational
2,106
1 country
1
Brief Summary
Background: Podoconiosis is a debilitating condition affecting one million people in Ethiopia. Podoconiosis is preventable if those at genetically high risk consistently protected their feet from exposure to silica nanoparticles present in clay soil. Despite the efforts of a local Non-Government Organization (NGO) the Mossy Foot Prevention \& Treatment Association (MFTPA) to distribute shoes to podoconiosis patients and their children, use of footwear is intermittent. This protocol proposes a collaboration among faculty from NHGRI, Addis Ababa University, and the MFTPA to develop and test intervention approaches that have the potential to be sustained by the community, to motivate children from families affected by podoconiosis to consistently wear shoes. Objective: The three primary aims are to: (1) use qualitative assessment strategies to explore factors influencing shoe use among high-risk children; (2) use these findings to develop culturally-tailored intervention modules; and (3) evaluate in a randomized trial the individual and joint effects of the intervention modules in encouraging high-risk children to consistently wear shoes. Population: Children (ages 9 -15) from families affected by podoconiosis who are participating in shoe distributions in one of 13 communities in the Wolaita zone of Ethiopia served by MFTPA. Methods: Guided by the PRECEDE-PROCEED approach to planning, implementing and evaluating public health programs, a two-phase study is proposed. Phase 1 will employ qualitative methods including participant observation, extended case studies, key-informant interviews and focus group discussions in a sample of 4 communities to gain understanding of the factors that influence shoe wear among high-risk children. Informed by these results, content for two modules (an enhanced education module and a role model support module) will be developed with the aim to motivate consistent use of footwear. Phase 2 will evaluate the individual and joint effectiveness of the two intervention modules in a randomized 2 x 2 factorial design with communities assigned randomly to one of 4 intervention conditions: (GP1) no enhanced health education and no role model support (usual care), (GP2) enhanced health education without role model support, (GP3) no enhanced health education with role model support, and (GP4) enhanced health education and role model support. All children receive shoes. Children will be surveyed at baseline, 3-5 days after shoe distribution, and again, 3- and 6- months post baseline. Outcomes: The primary outcome is a composite of direct observation of shoe use, self-reported shoe use, and baseline-to-follow-up changes in the children s foot appearance based on a visual foot exam. ...
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2010
CompletedFirst Submitted
Initial submission to the registry
July 9, 2010
CompletedFirst Posted
Study publicly available on registry
July 12, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2016
CompletedDecember 17, 2019
April 14, 2016
July 9, 2010
December 14, 2019
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Children 9-15 years of age who have been identified to participate in the MFTPA shoe distribution.
You may not qualify if:
- Children younger than 9 or older than 15
- Children who show clinical evidence of podoconiosis or have confirmed diagnosis of another pathology that might affect participation in study activities (for example tuberculosis)
- Children for whom we are unable to gain parental permission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Public Health Addis Ababa University
Addis Ababa, Ethiopia
Related Publications (3)
Abebe T, Aase A. Children, AIDS and the politics of orphan care in Ethiopia: the extended family revisited. Soc Sci Med. 2007 May;64(10):2058-69. doi: 10.1016/j.socscimed.2007.02.004. Epub 2007 Mar 26.
PMID: 17379371BACKGROUNDAyaya SO, Esamai FO. Health problems of street children in Eldoret, Kenya. East Afr Med J. 2001 Dec;78(12):624-9. doi: 10.4314/eamj.v78i12.8930.
PMID: 12199442BACKGROUNDDavey G, Tekola F, Newport MJ. Podoconiosis: non-infectious geochemical elephantiasis. Trans R Soc Trop Med Hyg. 2007 Dec;101(12):1175-80. doi: 10.1016/j.trstmh.2007.08.013. Epub 2007 Oct 31.
PMID: 17976670BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vence L Bonham, J.D.
National Human Genome Research Institute (NHGRI)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2010
First Posted
July 12, 2010
Study Start
June 14, 2010
Study Completion
April 14, 2016
Last Updated
December 17, 2019
Record last verified: 2016-04-14